Why are biotechnology stocks down today

IBD’s coverage of the biotech stock news and pharma stocks today keeps you on top of these fast-moving companies. Today’s laggard could be a biotech stock to watch tomorrow. Investors are again worried about a biotech bubble as biotech stocks take another big hit this week. Since April 23, the Nasdaq Biotechnology Index has dropped 6.8%. During the same time, the S&P Biotechnology Industry Index is down 8.5%. Some of the most popular biotech stocks are feeling the brunt of it. Bristol-Myers shares were indicated higher in pre-market trading Monday after the group said a new cancer treatment, which it acquired through its $74 billion takeover of Celgene Corp., had solid

29 Sep 2015 Biotech stocks got crushed again on Monday. The S&P biotech index is now down 23% below its July peak. It signals that the stocks are in bear  28 Sep 2015 CEO backs down after drug price hike Long a favorite of investors, biotech stocks have stumbled amid concerns that Glencore's troubles are " reverberating throughout the rest of the markets today," said Aknur Patel, chief  Shares of tiny biotech iBio Inc. surged another 19% in premarket trade Thursday, on continued strong hopes for its partnership with a Chinese company on a plant-based vaccine to treat the coronavirus. Biotech stocks fell into one of the deepest craters in their history, starting last summer, but rumblings of a recovery are sounding. After a three-year bull run that more than quadrupled its value by its peak last July, IBD's Medical-Biomed/Biotech Industry Group plunged 50% by early February,

15 Jan 2020 While the S&P 500 rose 30% during the year, many biotech stocks soared much higher. for a correction, whether it's this year or sometime down the road. valuations and neglect how much a company has proven today.

28 Sep 2015 CEO backs down after drug price hike Long a favorite of investors, biotech stocks have stumbled amid concerns that Glencore's troubles are " reverberating throughout the rest of the markets today," said Aknur Patel, chief  Shares of tiny biotech iBio Inc. surged another 19% in premarket trade Thursday, on continued strong hopes for its partnership with a Chinese company on a plant-based vaccine to treat the coronavirus. Biotech stocks fell into one of the deepest craters in their history, starting last summer, but rumblings of a recovery are sounding. After a three-year bull run that more than quadrupled its value by its peak last July, IBD's Medical-Biomed/Biotech Industry Group plunged 50% by early February, Biotech and Pharma. FDA finds impurity in popular heartburn medicine Zantac that could cause cancer. Connecticut says 11 people have been hospitalized due to severe lung injury linked to vaping. U.S. officials worried about Chinese control of American drug supply. Biotech start-up 10x Genomics surges in IPO debut. 2019 has not been a great year to own biotech stocks (so far). Since the year began, the Nasdaq Biotechnology Index (NBI) is down more than six percentage points, against near 16% rise for the S&P That's unusual, even for a pre-revenue biotech, suggesting that Verastem's shares might be near a bottom. Secondly, Copiktra's sales are projected to pick up steam from here on out, perhaps making this beaten-down biotech stock a great pick at these levels. IBD’s coverage of the biotech stock news and pharma stocks today keeps you on top of these fast-moving companies. Today’s laggard could be a biotech stock to watch tomorrow.

Shares of tiny biotech iBio Inc. surged another 19% in premarket trade Thursday, on continued strong hopes for its partnership with a Chinese company on a plant-based vaccine to treat the coronavirus.

The latest pharmaceutical industry news from MarketWatch. Is coronavirus airborne? Will it survive for hours or days on bathroom surfaces? Current opinion and analysis of the healthcare and biotech sector, including stock ideas, strategies and analysis. Biotech stock indices have fallen nearly five times as much as the broader NASDAQ this year, plunging 25% since January 4. Compared to a 5% decline in the NASDAQ.

6 May 2016 Biotech stock indices have fallen nearly five times as much as the broader Biotechnology Index (IBB) and the S&P Biotech ETF (XBI) down 

29 Sep 2015 Biotech stocks got crushed again on Monday. The S&P biotech index is now down 23% below its July peak. It signals that the stocks are in bear  28 Sep 2015 CEO backs down after drug price hike Long a favorite of investors, biotech stocks have stumbled amid concerns that Glencore's troubles are " reverberating throughout the rest of the markets today," said Aknur Patel, chief  Shares of tiny biotech iBio Inc. surged another 19% in premarket trade Thursday, on continued strong hopes for its partnership with a Chinese company on a plant-based vaccine to treat the coronavirus. Biotech stocks fell into one of the deepest craters in their history, starting last summer, but rumblings of a recovery are sounding. After a three-year bull run that more than quadrupled its value by its peak last July, IBD's Medical-Biomed/Biotech Industry Group plunged 50% by early February, Biotech and Pharma. FDA finds impurity in popular heartburn medicine Zantac that could cause cancer. Connecticut says 11 people have been hospitalized due to severe lung injury linked to vaping. U.S. officials worried about Chinese control of American drug supply. Biotech start-up 10x Genomics surges in IPO debut. 2019 has not been a great year to own biotech stocks (so far). Since the year began, the Nasdaq Biotechnology Index (NBI) is down more than six percentage points, against near 16% rise for the S&P That's unusual, even for a pre-revenue biotech, suggesting that Verastem's shares might be near a bottom. Secondly, Copiktra's sales are projected to pick up steam from here on out, perhaps making this beaten-down biotech stock a great pick at these levels.

Shares of tiny biotech iBio Inc. surged another 19% in premarket trade Thursday, on continued strong hopes for its partnership with a Chinese company on a plant-based vaccine to treat the coronavirus.

Find the latest stock market trends and activity today. Compare key indexes, including Nasdaq Composite, Nasdaq-100, Dow Jones Industrial & more. Fortune magazine reported that biotech stocks have fallen 25 percent this year, and with numbers that substantial, there have to be several causes at play. So why is biotech down — and more Bristol-Myers shares were indicated higher in pre-market trading Monday after the group said a new cancer treatment, which it acquired through its $74 billion takeover of Celgene Corp., had solid Why Biotech Stocks Face Steep Declines Ahead the more likely it is that the group will break down and retest the lows of around $101 seen in early February. For now, it seems the biotech Biotech Stock Down 50% Today. While Apple (AAPL) earnings are dominating headlines today, a handful of biotech stocks are also swimming in red ink. In fact, Puma Biotechnology Inc The latest pharmaceutical industry news from MarketWatch. Is coronavirus airborne? Will it survive for hours or days on bathroom surfaces?

Inovio Pharmaceuticals Inc (NASDAQ: INO) stock is on a volatile up-and-down ride as investors appear uncertain about its claims regarding a breakthrough in the  10 Mar 2020 Drugmaker Gilead Sciences Inc. fell as much as 6.4% shortly after the market opened, before ending the day down 1.6%. In contrast, the  9 Mar 2020 Look for biotech stocks as a group to gain more than 20% this year … with the An initial $1,000 investment would be worth about $748,000 today It's down about 3.5% here in 2020, so it has held up much better than the